181 related articles for article (PubMed ID: 22546767)
1. Gentamicin pharmacokinetics during continuous venovenous hemofiltration in critically ill septic patients.
Petejova N; Zahalkova J; Duricova J; Kacirova I; Brozmanova H; Urbanek K; Grundmann M; Martinek A
J Chemother; 2012 Apr; 24(2):107-12. PubMed ID: 22546767
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.
Petejova N; Martinek A; Zahalkova J; Duricova J; Brozmannova H; Urbanek K; Grundmann M; Plasek J; Kacirova I
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):65-72. PubMed ID: 23132513
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
Radej J; Krouzecky A; Stehlik P; Sykora R; Chvojka J; Karvunidis T; Novak I; Matejovic M
Ther Drug Monit; 2011 Aug; 33(4):393-7. PubMed ID: 21654349
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients.
Guenter SG; Iven H; Boos C; Bruch HP; Muhl E
Pharmacotherapy; 2002 Feb; 22(2):175-83. PubMed ID: 11837556
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration.
Jamal JA; Roberts DM; Udy AA; Mat-Nor MB; Mohamad-Nor FS; Wallis SC; Lipman J; Roberts JA
Int J Antimicrob Agents; 2015 Jul; 46(1):39-44. PubMed ID: 25881872
[TBL] [Abstract][Full Text] [Related]
6. Phenytoin removal by continuous venovenous hemofiltration.
Oltrogge KM; Peppard WJ; Saleh M; Regner KR; Herrmann DJ
Ann Pharmacother; 2013 Sep; 47(9):1218-22. PubMed ID: 24259740
[TBL] [Abstract][Full Text] [Related]
7. Fluconazole pharmacokinetics in a morbidly obese, critically ill patient receiving continuous venovenous hemofiltration.
Lopez ND; Phillips KM
Pharmacotherapy; 2014 Sep; 34(9):e162-8. PubMed ID: 25074285
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
[TBL] [Abstract][Full Text] [Related]
9. Single-dose pharmacokinetics of ofloxacin during continuous venovenous hemofiltration in critical care patients.
Fuhrmann V; Schenk P; Mittermayer C; El Menyawi I; Ratheiser K; Thalhammer F
Am J Kidney Dis; 2003 Aug; 42(2):310-4. PubMed ID: 12900813
[TBL] [Abstract][Full Text] [Related]
10. Delivered dose of continuous venovenous hemofiltration predicts outcome in septic patients with acute kidney injury: a retrospective study.
Nurmohamed SA; Koning MV; Vervloet MG; Groeneveld AB
J Crit Care; 2011 Apr; 26(2):213-20. PubMed ID: 21036524
[TBL] [Abstract][Full Text] [Related]
11. Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosing.
Bouman CS; van Kan HJ; Koopmans RP; Korevaar JC; Schultz MJ; Vroom MB
Intensive Care Med; 2006 Dec; 32(12):2013-9. PubMed ID: 17043848
[TBL] [Abstract][Full Text] [Related]
12. Variable pharmacokinetics of extended interval tobramycin or gentamicin among critically ill patients undergoing continuous venovenous hemofiltration.
Chuk AC; Saeed F; Kousar N; Burrill S; Barns B; Rickrode G; Fu J; Katrych O; Saunders-Hao P; Block C; Lahey T
Clin Nephrol; 2015 Oct; 84(4):214-21. PubMed ID: 26308080
[TBL] [Abstract][Full Text] [Related]
13. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration.
Heering P; Morgera S; Schmitz FJ; Schmitz G; Willers R; Schultheiss HP; Strauer BE; Grabensee B
Intensive Care Med; 1997 Mar; 23(3):288-96. PubMed ID: 9083231
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration.
Jamal JA; Mat-Nor MB; Mohamad-Nor FS; Udy AA; Wallis SC; Lipman J; Roberts JA
Int J Antimicrob Agents; 2015 Jan; 45(1):41-5. PubMed ID: 25455853
[TBL] [Abstract][Full Text] [Related]
15. Clearance of ceftazidime during continuous venovenous haemofiltration in critically ill patients.
Traunmüller F; Schenk P; Mittermeyer C; Thalhammer-Scherrer R; Ratheiser K; Thalhammer F
J Antimicrob Chemother; 2002 Jan; 49(1):129-34. PubMed ID: 11751776
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic modeling and dosage adaptation of biapenem in Japanese patients during continuous venovenous hemodiafiltration.
Ikawa K; Morikawa N; Ikeda K; Suyama H
J Infect Chemother; 2008 Feb; 14(1):35-9. PubMed ID: 18297447
[TBL] [Abstract][Full Text] [Related]
17. The effect of continuous venovenous hemofiltration on neutrophil gelatinase-associated lipocalin plasma levels in patients with septic acute kidney injury.
Dai X; Li T; Zeng Z; Fu C; Wang S; Cai Y; Chen Z
BMC Nephrol; 2016 Oct; 17(1):154. PubMed ID: 27760529
[TBL] [Abstract][Full Text] [Related]
18. Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment.
Jiang SP; Xu YY; Ping-Yang ; Wu WF; Zhang XG; Lu XY; Xiao YH; Liang WF; Chen J
Eur J Intern Med; 2014 Dec; 25(10):930-5. PubMed ID: 25153537
[TBL] [Abstract][Full Text] [Related]
19. Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
Roberts JA; Udy AA; Bulitta JB; Stuart J; Jarrett P; Starr T; Lassig-Smith M; Roberts NA; Dunlop R; Hayashi Y; Wallis SC; Lipman J
J Antimicrob Chemother; 2014 Sep; 69(9):2508-16. PubMed ID: 24879665
[TBL] [Abstract][Full Text] [Related]
20. Multiple-dose pharmacokinetics of linezolid during continuous venovenous haemofiltration.
Meyer B; Kornek GV; Nikfardjam M; Karth GD; Heinz G; Locker GJ; Jaeger W; Thalhammer F
J Antimicrob Chemother; 2005 Jul; 56(1):172-9. PubMed ID: 15905303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
